After the announcement yesterday, Abbott shares edged up 0.6%, finishing at $113.29. The AVEIR leadless pacemaker remains one of the key drivers of the Rhythm Management business. By continuously ...

Abbott has completed the first-in-human procedures for leadless left bundle branch area pacing (LBBAP) using its AVEIR conduction system pacing (CSP) leadless pacemaker system. The investigational ...

Trinity Health Muskegon was the first in the region to implant a new innovative pacemaker. The AVEIR DR, made by Abbott, is the world's first dual-chamber leadless pacemaker. "It's an exciting ...

(RTTNews) - Abbott (ABT) announced the successful completion of the world's first in-human leadless left bundle branch area pacing procedures using the company's investigational AVEIR Conduction ...